Skip to main content
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1974 Jun;47(2):113–122.

Commentary. EB virus, infectious mononucleosis, and cancer: the closing of the web.

A S Evans
PMCID: PMC2596416  PMID: 4372814

Full text

PDF
113

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Banatvala J. E., Best J. M., Waller D. K. Epstein-Barr virus-specific IgM in infectious mononucleosis, Burkitt lymphoma, nasopharyngeal carcinoma. Lancet. 1972 Jun 3;1(7762):1205–1208. doi: 10.1016/s0140-6736(72)90925-7. [DOI] [PubMed] [Google Scholar]
  2. Bausher J. C., Smith R. T. Studies of the Epstein-Barr virus-host relationship: autochthonous and allogeneic lymphocyte stimulation by lymphoblast cell lines in mixed cell culture. Clin Immunol Immunopathol. 1973 Jan;1(2):270–281. doi: 10.1016/0090-1229(73)90027-5. [DOI] [PubMed] [Google Scholar]
  3. Belcher R. W., Carney J. F., Nankervis G. A. Effect of sera from patients with sarcoidosis on in vitro lymphocyte response. Int Arch Allergy Appl Immunol. 1974;46(2):183–190. doi: 10.1159/000231122. [DOI] [PubMed] [Google Scholar]
  4. Byrne E. B., Evans A. S., Fouts D. W., Israel H. L. A seroepidemiological study of Epstein-Barr virus and other viral antigens in sarcoidosis. Am J Epidemiol. 1973 May;97(5):355–363. doi: 10.1093/oxfordjournals.aje.a121516. [DOI] [PubMed] [Google Scholar]
  5. Carvalho R. P., Evans A. S., Frost P., Dalldorf G., Camargo M. E., Jamra M. EBV infections in Brazil. I. Occurrence in normal persons, in lymphomas and in leukemias. Int J Cancer. 1973 Jan 15;11(1):191–201. doi: 10.1002/ijc.2910110123. [DOI] [PubMed] [Google Scholar]
  6. Chang R. S., Golden H. D. Transformation of human leucocytes by throat washing from infectious mononucleosis patients. Nature. 1971 Dec 10;234(5328):359–360. doi: 10.1038/234359a0. [DOI] [PubMed] [Google Scholar]
  7. De Schryver A., Klein G., Henle G., Henle W., Cameron H. M., Santesson L., Clifford P. EB-virus associated serology in malignant disease: antibody levels to viral capsid antigens (VCA), membrane antigens (MA) and early antigens(EA) in patients with various neoplastic conditions. Int J Cancer. 1972 Mar 15;9(2):353–364. doi: 10.1002/ijc.2910090214. [DOI] [PubMed] [Google Scholar]
  8. Epstein M. A., Achong B. G. Various forms of Epstein-Barr virus infection in man: established facts and a general concept. Lancet. 1973 Oct 13;2(7833):836–839. doi: 10.1016/s0140-6736(73)90874-x. [DOI] [PubMed] [Google Scholar]
  9. Epstein M. A., Hunt R. D., Rabin H. Pilot experiments with EB virus in owl monkeys (Aotus trivirgatus). I Reticuloproliferative disease in an inoculated animal. Int J Cancer. 1973 Sep 15;12(2):309–318. doi: 10.1002/ijc.2910120202. [DOI] [PubMed] [Google Scholar]
  10. Evans A. S., Niederman J. C., McCollum R. W. Seroepidemiologic studies of infectious mononucleosis with EB virus. N Engl J Med. 1968 Nov 21;279(21):1121–1127. doi: 10.1056/NEJM196811212792101. [DOI] [PubMed] [Google Scholar]
  11. Evans A. S., Rothfield N. F. E.B. virus and other viral antibodies in systemic lupus erythematosus. Lancet. 1973 May 19;1(7812):1127–1128. doi: 10.1016/s0140-6736(73)90444-3. [DOI] [PubMed] [Google Scholar]
  12. Evans A. S. The spectrum of infections with Epstein-Barr virus: a hypothesis. J Infect Dis. 1971 Sep;124(3):330–337. doi: 10.1093/infdis/124.3.330. [DOI] [PubMed] [Google Scholar]
  13. Fass L., Herberman R. B., Ziegler J. Delayed cutaneous hypersensitivity reactions to autologous extracts of Burkitt-lymphoma cells. N Engl J Med. 1970 Apr 2;282(14):776–780. doi: 10.1056/NEJM197004022821404. [DOI] [PubMed] [Google Scholar]
  14. Gerber P., Lucas S. J. In vitro stimulation of human lymphocytes by Epstein-Barr virus. Cell Immunol. 1972 Oct;5(2):318–324. doi: 10.1016/0008-8749(72)90057-3. [DOI] [PubMed] [Google Scholar]
  15. Gerber P., Lucas S., Nonoyama M., Perlin E., Goldstein L. I. Oral excretion of Epstein-Barr virus by healthy subjects and patients with infectious mononucleosis. Lancet. 1972 Nov 11;2(7785):988–989. doi: 10.1016/s0140-6736(72)92402-6. [DOI] [PubMed] [Google Scholar]
  16. Glade P. R., Hirschhorn K. Cellular immunity: immune responses and the herpes-like virus. Cell Immunol. 1970 Oct;1(4):359–361. doi: 10.1016/0008-8749(70)90013-4. [DOI] [PubMed] [Google Scholar]
  17. Glaser R., Rapp F. Rescue of Epstein-Barr virus from somatic cell hybrids of Burkitt lymphoblastoid cells. J Virol. 1972 Aug;10(2):288–296. doi: 10.1128/jvi.10.2.288-296.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Grumet F. C., Coukell A., Bodmer J. G., Bodmer W. F., McDevitt H. O. Histocompatibility (HL-A) antigens associated with systemic lupus erythematosus. A possible genetic predisposition to disease. N Engl J Med. 1971 Jul 22;285(4):193–196. doi: 10.1056/NEJM197107222850403. [DOI] [PubMed] [Google Scholar]
  19. Hampar B., Hsu K. C., Martos L. M., Walker J. L. Serologic evidence that a herpes-type virus is the etiologic agent of heterophile-positive infectious mononucleosis. Proc Natl Acad Sci U S A. 1971 Jul;68(7):1407–1411. doi: 10.1073/pnas.68.7.1407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Hardy D. A., Steel C. M. Cytotoxic potential of lymphocytes stimulated with autochthonous lymphoid cell line cells. Experientia. 1971;27(11):1336–1338. doi: 10.1007/BF02136724. [DOI] [PubMed] [Google Scholar]
  21. Henderson B. E., Dworsky R., Menck H., Alena B., Henle W., Henle G., Terasaki P., Newell G. R., Rawlings W., Kinnear B. K. Case-control study of Hodgkin's disease. II. Herpesvirus group antibody titers and HL-A type. J Natl Cancer Inst. 1973 Nov;51(5):1443–1447. [PubMed] [Google Scholar]
  22. Henle G., Henle W., Diehl V. Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis. Proc Natl Acad Sci U S A. 1968 Jan;59(1):94–101. doi: 10.1073/pnas.59.1.94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Hirshaut Y., Cohen M. H., Stevens D. A. Epstein-Barr-virus antibodies in American and African Burkitt's lymphoma. Lancet. 1973 Jul 21;2(7821):114–116. doi: 10.1016/s0140-6736(73)93061-4. [DOI] [PubMed] [Google Scholar]
  24. Hirshaut Y., Glade P., Vieira B. D., Ainbender E., Dvorak B., Siltzbach L. E. Sarcoidosis, another disease associated with serologic evidence for herpes-like virus infection. N Engl J Med. 1970 Sep 3;283(10):502–506. doi: 10.1056/NEJM197009032831002. [DOI] [PubMed] [Google Scholar]
  25. Ho J. H. Nasopharyngeal carcinoma (NPC). Adv Cancer Res. 1972;15:57–92. doi: 10.1016/s0065-230x(08)60372-3. [DOI] [PubMed] [Google Scholar]
  26. Hollinger F. B., Sharp J. T., Lidsky M. D., Rawls W. E. Antibodies to viral antigens in systemic lupus erythematosus. Arthritis Rheum. 1971 Jan-Feb;14(1):1–11. doi: 10.1002/art.1780140102. [DOI] [PubMed] [Google Scholar]
  27. Hurd E. R., Dowdle W., Casey H., Ziff M. Virus antibody levels in systemic lupus erythematosus. Arthritis Rheum. 1972 May-Jun;15(3):267–274. doi: 10.1002/art.1780150308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Johansson B., Klein G., Henle W., Henle G. Epstein-Barr virus (EBV)-associated antibody patterns in malignant lymphoma and leukemia. I. Hodgkin's disease. Int J Cancer. 1970 Nov 15;6(3):450–462. doi: 10.1002/ijc.2910060316. [DOI] [PubMed] [Google Scholar]
  29. Junge U., Hoekstra J., Deinhardt F. Stimulation of peripheral lymphocytes by allogeneic and autochthonous mononucleosis lymphocyte cell lines. J Immunol. 1971 May;106(5):1306–1315. [PubMed] [Google Scholar]
  30. Kafuko G. W., Henderson B. E., Kirya B. G., Munube G. M., Tukei P. M., Day N. E., Henle G., Henle W., Morrow R. H., Pike M. C. Epstein-Barr virus antibody levels in children from the West Nile District of Uganda. Report of a field study. Lancet. 1972 Apr 1;1(7753):706–709. doi: 10.1016/s0140-6736(72)90228-0. [DOI] [PubMed] [Google Scholar]
  31. Kufe D., Magrath I. T., Ziegler J. L., Spiegelman S. Burkitt's tumors contain particles encapsulating RNA-instructed DNA polymerase and high molecular weight virus-related RNA. Proc Natl Acad Sci U S A. 1973 Mar;70(3):737–741. doi: 10.1073/pnas.70.3.737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Levine P. H., Ablashi D. V., Berard C. W., Carbone P. P., Waggoner D. E., Malan L. Elevated antibody titers to Epstein-Barr virus in Hodgkin's disease. Cancer. 1971 Feb;27(2):416–421. doi: 10.1002/1097-0142(197102)27:2<416::aid-cncr2820270227>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  33. Levine P. H., O'Conor G. T., Bernard C. W. Antibodies to Epstein-Barr virus (EBV) in American patients with Burkitt's lymphoma. Cancer. 1972 Sep;30(3):610–615. doi: 10.1002/1097-0142(197209)30:3<610::aid-cncr2820300303>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  34. Miller G., Niederman J. C., Andrews L. L. Prolonged oropharyngeal excretion of Epstein-Barr virus after infectious mononucleosis. N Engl J Med. 1973 Feb 1;288(5):229–232. doi: 10.1056/NEJM197302012880503. [DOI] [PubMed] [Google Scholar]
  35. Niederman J. C., Evans A. S., Subrahmanyan L., McCollum R. W. Prevalence, incidence and persistence of EB virus antibody in young adults. N Engl J Med. 1970 Feb 12;282(7):361–365. doi: 10.1056/NEJM197002122820704. [DOI] [PubMed] [Google Scholar]
  36. Nonoyama M., Pagano J. S. Homology between Epstein-Barr virus DNA and viral DNA from Burkitt's lymphoma and nasopharyngeal carcinoma determined by DNA-DNA reassociation kinetics. Nature. 1973 Mar 2;242(5392):44–47. doi: 10.1038/242044a0. [DOI] [PubMed] [Google Scholar]
  37. Notkins A. L., Mahar S., Scheele C., Goffman J. Infectious virus-antibody complex in the blood of chronically infected mice. J Exp Med. 1966 Jul 1;124(1):81–97. doi: 10.1084/jem.124.1.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Oldstone M. B., Aoki T., Dixon F. J. The antibody response of mice to murine leukemia virus in spontaneous infection: absence of classical immunologic tolerance (AKR mice-complement-fixing antibodies-lymphocytic choriomeningitis virus-immunofluorescence-glomerular deposits of antigen-antibody complexes). Proc Natl Acad Sci U S A. 1972 Jan;69(1):134–138. doi: 10.1073/pnas.69.1.134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Oldstone M. B., Dixon F. J. Lymphocytic choriomeningitis: production of antibody by "tolerant" infected mice. Science. 1967 Dec 1;158(3805):1193–1195. doi: 10.1126/science.158.3805.1193. [DOI] [PubMed] [Google Scholar]
  40. Pagano J. S., Huang C. H., Levine P. Absence of Epstein-Barr viral DNA in Amercian Burkitt's lymphoma. N Engl J Med. 1973 Dec 27;289(26):1395–1399. doi: 10.1056/NEJM197312272892604. [DOI] [PubMed] [Google Scholar]
  41. Palmer E. L., Feorino P. M., Martin M. L. Increased antibody to herpes simplex virus in patients with nasopharyngeal cancer. J Infect Dis. 1972 Aug;126(2):186–188. doi: 10.1093/infdis/126.2.186. [DOI] [PubMed] [Google Scholar]
  42. Reedman B. M., Klein G. Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer. 1973 May;11(3):499–520. doi: 10.1002/ijc.2910110302. [DOI] [PubMed] [Google Scholar]
  43. Rothfield N. F., Evans A. S., Niederman J. C. Clinical and laboratory aspects of raised virus antibody titres in systemic lupus erythematosus. Ann Rheum Dis. 1973 May;32(3):238–246. doi: 10.1136/ard.32.3.238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Schmitz H., Scherer M. IgM antibodies to Epstein-Barr virus in infectious mononucleosis. Arch Gesamte Virusforsch. 1972;37(4):332–339. doi: 10.1007/BF01241456. [DOI] [PubMed] [Google Scholar]
  45. Shope T., Dechairo D., Miller G. Malignant lymphoma in cottontop marmosets after inoculation with Epstein-Barr virus. Proc Natl Acad Sci U S A. 1973 Sep;70(9):2487–2491. doi: 10.1073/pnas.70.9.2487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Shope T., Miller G. Epstein-Barr virus. Heterophile responses in squirrel monkeys inoculated with virus-transformed autologous leukocytes. J Exp Med. 1973 Jan 1;137(1):140–147. doi: 10.1084/jem.137.1.140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Simons M. J., Wee G. B., Day N. E., Morris P. J., Shanmugaratnam K., De-Thé G. B. Immunogenetic aspects of nasopharyngeal carcinoma: I. Differences in HL-A antigen profiles between patients and control groups. Int J Cancer. 1974 Jan 15;13(1):122–134. doi: 10.1002/ijc.2910130114. [DOI] [PubMed] [Google Scholar]
  48. Stell C. M., Ling N. R. Letter: Immunopathology of infectious mononucleosis. Lancet. 1973 Oct 13;2(7833):861–862. doi: 10.1016/s0140-6736(73)90924-0. [DOI] [PubMed] [Google Scholar]
  49. Strauch B., Andrews L. L., Siegel N., Miller G. Oropharyngeal excretion of Epstein-Barr virus by renal transplant recipients and other patients treated with immunosuppressive drugs. Lancet. 1974 Feb 16;1(7851):234–237. doi: 10.1016/s0140-6736(74)92546-x. [DOI] [PubMed] [Google Scholar]
  50. Virolainen M., Andersson L. C., Lalla M., von Essen R. T-lymphocyte proliferation in mononucleosis. Clin Immunol Immunopathol. 1973 Nov;2(1):114–120. doi: 10.1016/0090-1229(73)90041-x. [DOI] [PubMed] [Google Scholar]
  51. Werner J., Pinto C. A., Haff R. F., Henle W., Henle G. Responses of gibbons to inoculation of Epstein-Barr virus. J Infect Dis. 1972 Dec;126(6):678–681. doi: 10.1093/infdis/126.6.678. [DOI] [PubMed] [Google Scholar]
  52. Wilson C. B., Dixon F. J., Evans A. S., Glassock R. J. Antiviral antibody responses in patients with renal diseases. Clin Immunol Immunopathol. 1973 Nov;2(1):121–132. doi: 10.1016/0090-1229(73)90042-1. [DOI] [PubMed] [Google Scholar]
  53. Wolf H., zur Hausen H., Becker V. EB viral genomes in epithelial nasopharyngeal carcinoma cells. Nat New Biol. 1973 Aug 22;244(138):245–247. doi: 10.1038/newbio244245a0. [DOI] [PubMed] [Google Scholar]
  54. zur Hausen H., Schulte-Holthausen H., Klein G., Henle W., Henle G., Clifford P., Santesson L. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature. 1970 Dec 12;228(5276):1056–1058. doi: 10.1038/2281056a0. [DOI] [PubMed] [Google Scholar]
  55. zur Hausen H., Schulte-Holthausen H., Wolf H., Dörries K., Egger H. Attempts to detect virus-specific DNA in human tumors. II. Nucleic acid hybridizations with complementary RNA of human herpes group viruses. Int J Cancer. 1974 May 15;13(5):657–664. doi: 10.1002/ijc.2910130510. [DOI] [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES